It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Inflammatory bowel disease (IBD) is a chronic intestinal disorder, with two main types: Crohn’s disease (CD) and ulcerative colitis (UC), whose molecular pathology is not well understood. The majority of IBD-associated SNPs are located in non-coding regions and are hard to characterize since regulatory regions in IBD are not known. Here we profile transcription start sites (TSSs) and enhancers in the descending colon of 94 IBD patients and controls. IBD-upregulated promoters and enhancers are highly enriched for IBD-associated SNPs and are bound by the same transcription factors. IBD-specific TSSs are associated to genes with roles in both inflammatory cascades and gut epithelia while TSSs distinguishing UC and CD are associated to gut epithelia functions. We find that as few as 35 TSSs can distinguish active CD, UC, and controls with 85% accuracy in an independent cohort. Our data constitute a foundation for understanding the molecular pathology, gene regulation, and genetics of IBD.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Department of Biology, University of Copenhagen, Copenhagen N, Denmark; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N, Denmark
2 Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen, Herlev, Denmark
3 Department of Biology, University of Copenhagen, Copenhagen N, Denmark; Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N, Denmark; Department of Gastroenterology, Medical Section, Herlev Hospital, University of Copenhagen, Herlev, Denmark
4 Department of Gastroenterology, Surgical Section, Herlev Hospital, Herlev, Denmark
5 Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N, Denmark
6 DTU Bioinformatics, Technical University of Denmark, Lyngby, Denmark
7 Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N, Denmark; The Finsen Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen N, Denmark; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, University of Copenhagen, Copenhagen N, Denmark
8 Department of Biotechnology and Biomedicine, Technical University of Denmark, Lyngby, Denmark
9 Department of Science and Environment (INM), Roskilde University, Roskilde, Denmark
10 Department of Biology, University of Copenhagen, Copenhagen N, Denmark
11 Hvidovre Hospital, Gastrounit Medical Division, University of Copenhagen, Hvidovre, Denmark; Hvidovre Hospital, Department of Clinical Microbiology, University of Copenhagen, Hvidovre, Denmark
12 Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen N, Denmark; Novo Nordisk Foundation Center for Stem Cell Biology, DanStem, University of Copenhagen, Copenhagen N, Denmark
13 Centre for Surgical Science, Department of Surgery, Zealand University Hospital, Koege, Denmark